Articles tagged with Menopause
A new post-hoc analysis of the ATTAIN-1 and -2 studies found significant and similar weight reductions for women of different menopausal status, with up to 14% body weight loss and 12.5cm waist circumference reduction
Researchers developed a safer alternative to traditional hormone replacement therapy, targeting only one estrogen receptor to promote metabolic protection and prevent tumor growth. The approach restored metabolic balance, improved liver function, and reduced risk of diseases like diabetes and high cholesterol.
A large Danish study found that current use of oral menopausal hormone therapy is associated with an increased risk of blood clots in legs/lungs, with no general increased risk seen with transdermal hormone therapy. Stroke and heart attack risks were limited to prolonged high-dose oral hormone therapy.
Researchers analyzed data from the Framingham Heart Study to investigate the relationship between menopause and aortic stiffness. The study found that factors other than menopause timing contributed to the increase in pulse pressure in women after midlife.
A US study of 20 years of health data found that hormone therapy initiated during peri- or early postmenopause reduces cardiovascular disease risk by 22% compared to those who did not use hormone therapy. The protective effect was strongest among Black women and those who initiated therapy within 10 years of menopause onset.
A study of nearly 400,000 women found menopause is inconsistently documented in electronic health records, with only 7% of women having it recorded. The study highlights the need for routine capture of reproductive health information to improve understanding of menopause and its impact on disease risk and health outcomes.
A study found that CADD522 strengthened bones in post-menopausal mice while reducing body fat and reversing metabolic changes linked to menopause. The treatment also appeared to reverse menopause-related changes in fatty acids and lipid abnormalities.
A new study suggests that estrogen hormone treatment combining estriol and progesterone may help alleviate 'brain fog' symptoms in menopausal women. The study found significant reductions in cognitive symptoms such as memory, concentration, and problem-solving after 12 months of treatment.
Researchers found that aerobic exercise significantly improves executive functions, including planning, task-switching, and focus, in post-menopausal women. Regular exercise can help preserve cognitive health and reduce the risk of Alzheimer's disease, with benefits observed as early as three months into the program.
A new study published in the Journal of the COPD Foundation suggests that women with a shorter reproductive lifespan are at greater risk of developing bronchiectasis. The study of nearly 97,000 postmenopausal women found that hormone therapy use was associated with a 19% greater risk of bronchiectasis.
A large UK study found that hormone replacement therapy (HRT) may reduce the risk of dementia, particularly for women who have undergone surgical menopause. The study, which followed over 180,000 postmenopausal women, found that HRT was associated with a 16% lower risk of developing Alzheimer's disease compared to non-users.
A new hypothesis proposes that women's reproductive resilience is key to understanding longevity, with menopause representing an important inflection point in the loss of reproductive resilience. This framework challenges traditional views on aging and fertility, highlighting the importance of studying women in longevity research.
A long-term study of 1,200 women in eastern Massachusetts found that those living in disadvantaged neighborhoods faced faster declines in heart health and worse cardiovascular risk before menopause. The research highlights the importance of addressing socioeconomic factors in preventing heart disease.
AI model improves cardiac MRI interpretation, while immersive VR simulators aid poststroke rehabilitation. Meanwhile, menopause tracking apps offer empowerment but also pose risks due to inaccurate information and targeted marketing.
A new study reveals that menopause symptoms such as cognitive impairment and emotional wellbeing are more commonly discussed on Reddit than in clinical records. The study highlights the importance of online forums in capturing stigmatized or poorly understood conditions like perimenopause and menopause.
A pooled data analysis of 44 countries reveals that early menopause is more prevalent in rural areas, but education and delayed childbearing minimize the risk. The overall prevalence was 7% among women aged 30-49, with the highest rates found in Ethiopia, Indonesia, and Myanmar.
Researchers at CU Anschutz have developed a promising nonhormonal therapy for women experiencing Genitourinary Syndrome of Menopause (GSM), which affects the vulva, vagina, and urinary tract. The therapy restores estrogen signaling in vaginal tissue without exposing the rest of the body to estrogen.
A retrospective cohort study found that menopausal hormone therapy significantly reduces the risk of low bone mineral density by 69% compared to non-users. This suggests that hormone therapy could be an effective way to prevent bone loss and lower fracture risks in women after menopause.
The first real-world study of fezolinetant found the treatment improved hot flashes, depression, and anxiety in women with menopausal vasomotor symptoms. In a study of 656 women, fezolinetant significantly reduced hot flash symptoms and showed benefits similar to those seen in clinical trials.
A new study published in Menopause journal found that replacing animal protein with plant-based sources like soybeans, beans, and grains leads to significant weight loss in postmenopausal women. The study's lead author suggests that the quality of protein, not just quantity, plays a key role in weight regulation and metabolic health.
A 20-year study in the UK, Australia, and US reveals a significant increase in menopause-related search patterns focused on commercial products and services. This shift indicates a growing need for non-clinical guidance and support beyond traditional clinical encounters.
A recent study found that hormone therapy use among US women has steadily declined from 4.4% in 2007 to 1.7% in 2023, despite its proven benefits for symptom relief and quality of life. The majority of women who could benefit from hormone therapy are not receiving it due to misconceptions about risks and limited training among clinicians.
A study found that 14 million workdays are lost annually due to menopause, while women rely on online misinformation for medical advice. The authors advocate for open conversation and inclusive approaches to combat stigma and support women's health during this transition.
A large study of nearly 40,000 women found that plant-based diets with lower insulinemic potential can help women manage their weight and reduce the risk of obesity during menopause. Women who followed a diet rich in whole grains, nuts, legumes, and vegetables had a significantly lower risk of developing obesity.
The Mount Sinai Health System has opened the Carolyn Rowan Center for Women’s Health and Wellness, which brings together multidisciplinary clinical expertise, structured care pathways, and leading-edge research to deliver personalized, comprehensive care for women. The Center offers guided multi-visit experiences and coordinated care o...
A new preclinical study finds that estrogen loss in the extracellular matrix of the hippocampus may contribute to memory decline and increased risk of Alzheimer's disease in postmenopausal women. The study suggests a possible new treatment approach focused on restoring the brain's supportive environment.
A report by the European Society of Cardiology advocates for dedicated women's heart centers to improve diagnosis and treatment of cardiovascular disease in women. These centers can enhance quality of life, reduce symptoms, and increase survival rates for women with cardiovascular disease.
Polyendocrine Ovarian Syndrome (PMOS) impacts 13% of women, causing hormonal imbalance, insulin resistance, and chronic pain. Lifestyle interventions, particularly diet and exercise, show benefits for physical and mental health outcomes.
NUTRITION 2026 will feature new, unpublished research findings relevant to consumer choices, clinical practice and public policy. The meeting is the premier place to dig deep into the discourse on what we eat and why it matters.
The ECE 2026 brings together researchers and clinicians to share the latest endocrine research and developments. Key sessions include Plenaries, Symposia, Awards, Meet the Experts, Debates, and Oral Communications.
Researchers have created a new scale to measure whether lactating mothers' psychological needs are being met, providing a tool to improve breastfeeding outcomes. The study found that when all three basic needs (autonomy, competence, and relatedness) are satisfied, exclusive breastfeeding is more likely to persist.
Dr. Hannah Cabré has been appointed as an Assistant Professor and Director of the Aging, Gynecology, and Endocrinology Laboratory at Pennington Biomedical Research Center. Her research focuses on the role of female sex hormones in shaping nutrition, health, and performance across the lifespan.
A new study reveals that menopause causes profound and uneven transformations across the female reproductive system, rather than a uniform decline. The research identified molecular signals associated with aging detectable in blood, allowing for non-invasive monitoring and earlier detection of risks.
A study published in Cells suggests that declining estrogen levels alter epigenetics, which may explain the rise in heart disease risk after menopause. The researchers identify a potential link between estrogen loss and changes in cardiovascular health.
The European Society of Endocrinology organizes World Hormone Day to educate the public about hormone-related health issues. Global endocrine disorders affect millions worldwide, emphasizing the need for proper hormone balance.
Replacing meat and dairy with plant-based foods reduces greenhouse gas emissions by 35%, equivalent to eliminating 600 miles of driving. A low-fat vegan diet with soybeans also produces major health improvements, including a 92% reduction in severe hot flashes.
A new study from Tulane University found that women with high predicted cardiovascular risk face nearly double the risk of hip fracture. The association was stronger in women under 65, and higher cardiovascular risk was linked to fractures in weakened bones in major areas.
Researchers from the University of Waterloo have identified the key factor behind estrogen's protective effects against high blood pressure, finding vasodilation to be the crucial mechanism. This discovery holds promise for more effective treatment options for women after menopause, when estrogen levels naturally decline.
The Alliance for Clinical Trials in Oncology will host a webinar highlighting recent clinical advances in breast cancer, multiple myeloma, and leukemia. Researchers will present key findings from ASH and SABCS meetings, impacting treatment outcomes.
A new collaborative clinician education program will equip cardiologists and OB-GYNs with practical tools to identify and treat cardiovascular risk in midlife women. The program aims to close treatment gaps and provide proactive, integrated care during menopause.
A large Danish study found that menopausal hormone therapy is not associated with an increased risk of death in women with moderate to severe symptoms and no contraindications. The study also showed a significant survival benefit for women who had undergone bilateral oophorectomy after using hormone therapy.
A nationwide Finnish registry-based study found no increased risk of pre- or postmenopausal breast cancer among women with a history of induced abortion or miscarriage. Breast cancer risks were similar regardless of the number of abortions or miscarriages, as well as the time of first abortion or miscarriage.
A global study of 17,494 people from 158 countries reveals a significant gap between expected and experienced perimenopause symptoms. Fatigue, mood changes, and sleep-related issues are the most common reported symptoms, with exhaustion and fatigue being particularly prevalent.
A study from the University of Cambridge found that menopause is associated with reduced grey matter volume in key brain regions, increased anxiety and depression, and difficulties with sleep. Despite hormone replacement therapy (HRT) not mitigating these effects, it can slow reaction times.
A new study from the University of Victoria found that higher insulin levels at age 47 predicted younger onsets of hot flashes and night sweats. Insulin may be a stronger predictor of hot flashes when taking other metabolic variables into account, while body mass index (BMI) appeared more closely associated with estrogen level changes.
Research by Bournemouth University explores the impact of menopause on autistic people, finding that symptoms can be disabling and life-threatening. The study highlights the need for better support and resources to help neurodivergent individuals navigate this transition.
The Global Centre for Asian Women’s Health has partnered with NUS Medicine to host the Women’s Health Impact Tracking (WHIT) platform, which measures progress on closing the women’s health gap across a set of conditions and countries. The platform provides clear, comparative insights to support decision-making and inform policies.
A comprehensive review of prior research found no evidence that menopause hormone therapy increases or decreases dementia risk in post-menopausal women. The study included data from over 1 million participants and analyzed the impact on mild cognitive impairment and Alzheimer's disease, with no significant association found.
A new study found menopause symptoms are frequently reported by female endurance athletes, with 88% experiencing sleep problems and 83% feeling physical and mental exhaustion. These symptoms negatively affect training and performance, particularly musculoskeletal changes and quality of life.
A study of over 10,000 women aged 65 and older found that moderate tea consumption was associated with higher bone mineral density, a key indicator of osteoporosis risk. In contrast, excessive coffee consumption, particularly in those who drink alcohol, may be detrimental to bone health.
The European Society of Endocrinology is launching a new campaign to raise awareness about the importance of hormone health. The #BecauseHormonesMatter initiative aims to improve public understanding of hormones and promote practical steps for better hormone health, following the success of last year's campaign.
A new study from the Kinsey Institute reveals that self-pleasure is a valuable care strategy for managing menopause symptoms, particularly mood and sleep changes. Most women surveyed are open to trying masturbation as a symptom management approach.
A six-week self-hypnosis program significantly reduced menopausal hot flashes by 53.4%, with a larger treatment effect seen in women with breast cancer history. The study suggests hypnotherapy as a safe and effective alternative to hormone replacement therapy.
A randomized clinical trial found that self-administered hypnosis significantly reduced hot flash scores and daily interference compared to sham hypnosis. The study suggests that hypnosis delivered through audio files is a clinically significant method for reducing hot flashes in postmenopausal women.
The FDA has revised the labeling for menopausal hormone therapy based on current evidence, which may affect patient safety and treatment options. The updated guidelines aim to provide more accurate information for healthcare providers and patients.
The $4 million gift from Jeff and Linda Moslow is supporting the Tufts Women's Health and Menopause Initiative, a unique academic collaboration between Tufts Medicine and the Friedman School of Nutrition Science and Policy. The initiative aims to advance clinical care, education, and research in women's health across the lifespan.
A Mayo Clinic study of nearly 5,000 midlife women found that over three-quarters experienced menopause symptoms, yet only one in four received treatment. The study highlights the importance of healthcare professionals identifying and managing menopause symptoms to improve women's health and quality of life.
The FDA has approved elinzanetant for treating hot flashes and night sweats in postmenopausal women. The drug significantly reduces the frequency and severity of symptoms while improving sleep quality and quality of life.
Researchers at the Mayo Clinic have found that platelet-rich plasma (PRP) treatment can significantly improve genitourinary syndrome of menopause (GSM) symptoms in breast cancer survivors. After six months, GSM symptoms such as sexual function, urinary symptoms and quality of life improved, even among those taking estrogen blockers.
The European Society of Endocrinology has published a new Clinical Practice Guideline for the Management and Evaluation of Menopause and the Perimenopause. The guideline provides guidance on evaluating and managing women with menopause-related symptoms, including hormone therapy benefits and risks. It also discusses alternative treatme...